VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology

Mutations in VPS35 (PARK17), a key molecule in the retromer complex, are a rare cause of autosomal dominant Parkinson's disease (PD), the second most common neurodegenerative disorder. VPS35 exerts crucial functions within the cell in terms of regulating endosomal trafficking. However new data...

Full description

Bibliographic Details
Main Authors: Gianni Cutillo, David K. Simon, Simona Eleuteri
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996120303314
_version_ 1818673477169709056
author Gianni Cutillo
David K. Simon
Simona Eleuteri
author_facet Gianni Cutillo
David K. Simon
Simona Eleuteri
author_sort Gianni Cutillo
collection DOAJ
description Mutations in VPS35 (PARK17), a key molecule in the retromer complex, are a rare cause of autosomal dominant Parkinson's disease (PD), the second most common neurodegenerative disorder. VPS35 exerts crucial functions within the cell in terms of regulating endosomal trafficking. However new data suggest its relevance also in the regulation of mitochondrial dynamics and homeostasis. Herein, we review the crosstalk between VPS35 and the mitochondria, highlighting the potential relevance to PD pathogenesis. VPS35 is not only a critical player in pathways connected to α-synuclein accumulation and clearance, but also plays a key role in ensuring mitochondrial stability and function. The genetic links of VPS35 to PD and the involvement of VPS35 in different PD related pathological mechanisms highlight the potential for targeting VPS35 as a neuroprotective strategy for PD.
first_indexed 2024-12-17T07:56:25Z
format Article
id doaj.art-47f8dc7c98804868875c6690717fb099
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-17T07:56:25Z
publishDate 2020-11-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-47f8dc7c98804868875c6690717fb0992022-12-21T21:57:40ZengElsevierNeurobiology of Disease1095-953X2020-11-01145105056VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiologyGianni Cutillo0David K. Simon1Simona Eleuteri2Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, MA 02215, USABeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, MA 02215, USACorresponding author.; Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, MA 02215, USAMutations in VPS35 (PARK17), a key molecule in the retromer complex, are a rare cause of autosomal dominant Parkinson's disease (PD), the second most common neurodegenerative disorder. VPS35 exerts crucial functions within the cell in terms of regulating endosomal trafficking. However new data suggest its relevance also in the regulation of mitochondrial dynamics and homeostasis. Herein, we review the crosstalk between VPS35 and the mitochondria, highlighting the potential relevance to PD pathogenesis. VPS35 is not only a critical player in pathways connected to α-synuclein accumulation and clearance, but also plays a key role in ensuring mitochondrial stability and function. The genetic links of VPS35 to PD and the involvement of VPS35 in different PD related pathological mechanisms highlight the potential for targeting VPS35 as a neuroprotective strategy for PD.http://www.sciencedirect.com/science/article/pii/S0969996120303314VPS35Endosomal traffickingParkinson's diseaseMitochondrial dynamicNeuroprotectionTherapeutic approach
spellingShingle Gianni Cutillo
David K. Simon
Simona Eleuteri
VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
Neurobiology of Disease
VPS35
Endosomal trafficking
Parkinson's disease
Mitochondrial dynamic
Neuroprotection
Therapeutic approach
title VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
title_full VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
title_fullStr VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
title_full_unstemmed VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
title_short VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology
title_sort vps35 and the mitochondria connecting the dots in parkinson s disease pathophysiology
topic VPS35
Endosomal trafficking
Parkinson's disease
Mitochondrial dynamic
Neuroprotection
Therapeutic approach
url http://www.sciencedirect.com/science/article/pii/S0969996120303314
work_keys_str_mv AT giannicutillo vps35andthemitochondriaconnectingthedotsinparkinsonsdiseasepathophysiology
AT davidksimon vps35andthemitochondriaconnectingthedotsinparkinsonsdiseasepathophysiology
AT simonaeleuteri vps35andthemitochondriaconnectingthedotsinparkinsonsdiseasepathophysiology